[go: up one dir, main page]

DK0544168T3 - Anvendelse af aminoalkyl-substituerede 5,6-dihydro-dibenz(b,e) azepin-6,11-dion-11-oximer som antivirale midler - Google Patents

Anvendelse af aminoalkyl-substituerede 5,6-dihydro-dibenz(b,e) azepin-6,11-dion-11-oximer som antivirale midler

Info

Publication number
DK0544168T3
DK0544168T3 DK92119530.1T DK92119530T DK0544168T3 DK 0544168 T3 DK0544168 T3 DK 0544168T3 DK 92119530 T DK92119530 T DK 92119530T DK 0544168 T3 DK0544168 T3 DK 0544168T3
Authority
DK
Denmark
Prior art keywords
azepine
aminoalkyl
dione
substituted
oxymers
Prior art date
Application number
DK92119530.1T
Other languages
English (en)
Inventor
Hanno Dr Wild
Wolfgang Dr Roeben
Gerd Dr Aichinger
Arnold Dr Paessens
Gehr Joerg Dr Petersen-Von
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0544168T3 publication Critical patent/DK0544168T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/20Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92119530.1T 1991-11-27 1992-11-16 Anvendelse af aminoalkyl-substituerede 5,6-dihydro-dibenz(b,e) azepin-6,11-dion-11-oximer som antivirale midler DK0544168T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4138909A DE4138909A1 (de) 1991-11-27 1991-11-27 Aminoalkyl-substituierte 5,6-dihydro-dibenz(b,e)azepin-6,11-dion-11-oxime

Publications (1)

Publication Number Publication Date
DK0544168T3 true DK0544168T3 (da) 1998-04-14

Family

ID=6445646

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92119530.1T DK0544168T3 (da) 1991-11-27 1992-11-16 Anvendelse af aminoalkyl-substituerede 5,6-dihydro-dibenz(b,e) azepin-6,11-dion-11-oximer som antivirale midler

Country Status (13)

Country Link
US (1) US5385899A (da)
EP (1) EP0544168B1 (da)
JP (1) JPH05262740A (da)
KR (1) KR930010004A (da)
AT (1) ATE157654T1 (da)
AU (1) AU650375B2 (da)
CA (1) CA2083771A1 (da)
DE (2) DE4138909A1 (da)
DK (1) DK0544168T3 (da)
HU (1) HUT65606A (da)
IL (1) IL103856A0 (da)
NZ (1) NZ245264A (da)
ZA (1) ZA929176B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4138908A1 (de) * 1991-11-27 1993-06-03 Bayer Ag 6-thiono-dibenz(b,e)azepine
US6071710A (en) * 1996-11-20 2000-06-06 Musc Foundation For Research Development Antikinin compounds and uses thereof
KR101705168B1 (ko) 2015-04-20 2017-02-10 현대자동차주식회사 내구성이 향상된 침탄 합금강 및 이의 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545856A1 (de) * 1965-09-10 1969-11-27 Bayer Ag Verfahren zur Herstellung von basisch substituierten Derivaten des 5,6-Dihydro-dibenz-[b,e]-azepin-6,11-dion-11-oxims
GB1132516A (en) * 1966-02-01 1968-11-06 Ici Ltd Morphanthridine derivatives
DE3531682A1 (de) * 1985-09-05 1987-03-12 Thomae Gmbh Dr K (+)-6-chlor-5,10-dihydro-5-((1-methyl-4- piperidinyl)acetyl)-11h-dibenzo(b,e)(1,4) diazepin-11-on, seine isolierung und verwendung als arzneimittel
US5037821A (en) * 1988-06-01 1991-08-06 E. R. Squibb & Sons, Inc. Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor

Also Published As

Publication number Publication date
EP0544168A1 (de) 1993-06-02
IL103856A0 (en) 1993-04-04
ATE157654T1 (de) 1997-09-15
JPH05262740A (ja) 1993-10-12
HUT65606A (en) 1994-07-28
US5385899A (en) 1995-01-31
CA2083771A1 (en) 1993-05-28
AU650375B2 (en) 1994-06-16
KR930010004A (ko) 1993-06-21
ZA929176B (en) 1993-05-25
AU2859892A (en) 1993-06-03
DE4138909A1 (de) 1993-06-03
NZ245264A (en) 1994-09-27
DE59208855D1 (de) 1997-10-09
EP0544168B1 (de) 1997-09-03

Similar Documents

Publication Publication Date Title
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
ATE226201T1 (de) Substituierte pyridylpyrazole
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
OA09770A (fr) "Dérivés de benzèneacétamide inhibiteurs du VIH".
DE69202164D1 (de) Stabilisierung von Thiolenzusammensetzungen.
IT1203945B (it) Agenti stabilizzanti costituiti da 1,3,2-ossazafosfolidine
KR910700089A (ko) 히드로클로로플루오로프로판의 공비 조성물 또는 공비형 조성물
EP0661972A4 (en) USE OF SPIPERON AND SPIPERON DERIVATIVES AS IMMUNE SUPPRESSIVE ACTIVE SUBSTANCES.
ITMI913465A1 (it) Procedimento per la depurazione dell'1, 1, 1-trifluoro-2-fluoroetano
DE69003075D1 (de) Stabilisierungszusammensetzungen.
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
DE69002520D1 (de) Azeotropaehnliche zusammensetzungen von 1,1-dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1-fluoraethan.
DK671087A (da) Anvendelse af 5-aryl-3h-1,2,4-triazol-3-oner som antikonvulsiva
DK0544168T3 (da) Anvendelse af aminoalkyl-substituerede 5,6-dihydro-dibenz(b,e) azepin-6,11-dion-11-oximer som antivirale midler
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
DE59207900D1 (de) Iloprost mit wirkung gegen cerebrale malaria
IT9047527A1 (it) Composizioni tensioattive, loro preparazione e loro impiego come agenti antischiuma. (caso 150-5294)
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
DE69208681D1 (de) Verwendungen von 1,1,1,3,3,3-hexafluoropropan
BR9704377A (pt) Composições de borracha contendo n,n'-bis (hidroxifenil) maleamida
DE69107897D1 (de) Verfahren zur Herstellung von N,N'-bis(tetrabromophthalimid).
DK0544171T3 (da) Anvendelse af 5,6-dihydro-dibenz(b,e)azepin-6,11-dion-11-oximer til fremstilling af antiretrovirale midler
DE69205045D1 (de) Herstellung von 3,5-Diaminobenzotrifluorid.
DK0412941T3 (da) Phospholipider til behandling af dissemineret sklerose
DE69102195D1 (de) Herstellung von 3,3,3-Trifluorpropen-1.